active pharmaceutical ingredients (APIs)

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has revealed that it will be investing in the expansion of chemical and analytical development capabilities at its Charles City, Iowa plant more

31 Jan 2018 13:50 News

Global active pharmaceutical ingredient (API) developer and manufacturer, Sterling Pharma Solutions, has experienced growth within the Japanese market and as such is now working with numerous clients in the region. more

24 Jan 2018 12:26 News

Tablet manufacturing poses many challenges and the development process of a tablet form is a critical step that requires the correct tools and equipment. In this article, Robert Sedlock, Natoli Engineering will discuss the three phases more

15 Dec 2017 09:00 Opinion

AMRI, a global contract research, development and manufacturing organisation, has doubled its bulk active pharmaceutical ingredient (API) aseptic manufacturing capacity with the addition of a multipurpose aseptic API line at its facility in Spain more

6 Dec 2017 14:40 News

Findings released by the CPhI Global Pharma Index have shown that India’s reputation is improving with the country proving to be successful in a number of key areas and is ranked as the third most competitive nation by international pharma companies. more

13 Nov 2017 14:40 Analysis

Piramal Pharma Solutions (PPS), a contract development and manufacturing organisation (CDMO), is investing $55 million across its sites in North America and Asia to expand its API manufacturing capabilities and capacities. more

11 Oct 2017 12:45 News

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex has installed a new, large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden. more

28 Sep 2017 12:08 News

Manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), Cambrex, is expanding its High Point, North Carolina facility with the addition of a new $3.2 million, 11,000 sq ft analytical laboratory. more

4 Sep 2017 12:19 Technology

Contract development and manufacturing organisation (CDMO), Avara Pharmaceutical Services, has acquired the Italian sterile manufacturing facility in an agreement with Pfizer. more

14 Aug 2017 13:42 News

CPhI has released the findings of its 2017 India Pharma Market Report, identifying improved international repute of India but an urgent call for government support for investment in active pharmaceutical ingredient (API) facilities. more

11 Aug 2017 11:57 Analysis

Cambrex, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), is investing $24 million in a new highly potent API manufacturing facility in Charles City, Iowa. more

10 Aug 2017 12:26 News

CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and API manufacturing company, has successfully completed Swissmedic inspections at three of its sites, resulting in the renewal of GMP certificates. more

25 Jul 2017 12:24 News

CRO and small scale active pharmaceutical ingredient (API) specialist, Onyx Scientific, has supported biotech company, TopiVert, in the initiation of clinical trials for two narrow spectrum kinase inhibitor (NSKI) drug candidates. more

20 Jul 2017 12:31 News

Specialty solutions provider, Quascenta, has released a software application, eResidue-API, designed to specifically to help active pharmaceutical ingredient (API) manufacturers streamline the cleaning validation process. more

13 Jul 2017 12:32 Technology

Lyophilisation is crucial in the creation of pharmaceutical ingredients with an extended shelf life, however, current methods can still be costly and time consuming. Hosokawa Micron reveals its new method of contained active freeze drying more

20 Jun 2017 10:55 Opinion

Doug Millington-Smith, principal applications specialist at powder characterisation company Freeman Technology, considers the value of multivariate powder characterisation as a solution to the demand for comprehensive data. more

19 Jun 2017 10:26 Opinion

Jonathan Knight, VP New Product Development at Cambrex, dissects the route used to manufacture APIs, highlighting those steps that can make a process ideal. more

16 Jun 2017 15:34 Opinion

Cambrex, manufacturer of small molecule active pharmaceutical ingredients (APIs), has announced it is investing in new capacity and continuous flow technology at its Karlskoga facility in Sweden. more

1 Jun 2017 11:35 News

The World Health Organisation (WHO) is seeking a new manufacturer of the active pharmaceutical ingredient (API) for levonorgestrel, the birth control drug, after the FDA placed the Chinese manufacturer on import alert. more

18 Apr 2017 12:20 News

RSSL’s physical chemistry department has revealed an expansion of its particle characterisation capabilities, which includes new equipment to measure the surface area of powder particles. more

31 Mar 2017 10:56 News